Basal cell carcinoma is the most common skin cancer, often caused by UV exposure, and originates in the epidermis's basal cells. Diagnosis involves clinical examination and biopsy to confirm BCC and ...
A systematic analysis demonstrated the rarity of super-giant basal cell carcinomas and the need for further characterization of these understudied skin cancers. Super-giant basal cell carcinoma (SGBCC ...
Basal cell carcinoma has low immunogenicity. Tumor cells express Foxc1 protein (red), which suppresses HLA class I (green) in the tumor cells. Compromised antigen presentation ranks among the top ...
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell ...
Basal cell carcinoma and squamous cell carcinoma are the two most common types of non-melanoma skin cancer. These cancers begin in different layers of the skin. Squamous cell carcinoma starts in the ...
Please provide your email address to receive an email when new articles are posted on . PDT with ALA works well in BCC treatment, but is limited by injection depth. Jet-injected PDT could be a viable ...
Basal cell carcinoma (BCC) represents the most prevalent form of skin cancer, with research efforts increasingly focused on elucidating its molecular underpinnings and improving therapeutic strategies ...
New York Gov. Kathy Hochul's skin-cancer removal treatment Friday underscored the importance of preventive screening protecting yourself from the sun. The 66-year-old governor announced a day earlier ...
Hosted on MSN
Basal cell carcinoma's low immunogenicity linked to suppression of antigen presentation from its cell of origin
Compromised antigen presentation ranks among the top mechanisms that render cancers non-immunogenic (non-responsive to immune-based therapies). Despite harboring the highest tumor mutational burden of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback